CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D-NKG2DL axis. - Lerner EC; Woroniecka KI; D'Anniballe VM; Wilkinson DS; Mohan AA; Lorrey SJ; Waibl-Polania J; Wachsmuth LP; Miggelbrink AM; Jackson JD; Cui X; Raj JA; et al. (Nature cancer, 2023)